logo-loader
viewConocoPhillips

ConocoPhillips to cut-back expenditure due to low oil price

The firm will reduce its spending to US$6.4bn for 2016 it announced on Thursday

BHP-Petroleum---oil-platform.jpg
ConocoPhillips also posted a fourth-quarter loss of US$3.5bn, or US$2.78 a share

Shares in energy giant ConocoPhillips (NYSE:COP) dropped as it confirmed it will continue to cut back on its capital expenditure in the wake of the slumping oil price.

The firm will reduce its spending to US$6.4bn for 2016 it announced on Thursday, including slashing its quarterly dividend.

ConocoPhillips said it will cut its quarterly dividend to 25 cents a share from the previous 74 cents a share.

Chairman and chief executive Ryan Lance said: “While we don't know how far commodity prices will fall, or the duration of the downturn, we believe it's prudent to plan for lower prices for a longer period of time.”

The company, which before the start of the New Year had forecast 2016 expenditure at US$7.7bn, also cut it operating cost estimate to U$7bn from US$7.7bn.

“The actions we have announced will improve net cash flow by US$4.4bn in 2016,” he added.

ConocoPhillips also posted a fourth-quarter loss of US$3.5bn, or US$2.78 a share largely due to a US$2.7bn in write-down of its assets, reflecting commodities price volatility.

Quick facts: ConocoPhillips

Price: 61.18 USD

NYSE:COP
Market: NYSE
Market Cap: $67.13 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: THC Global Group granted GMP Licence for Southport cannabis...

THC Global Group Limited (ASX:THC) chief executive officer Ken Charteris updates Proactive on being granted a licence to manufacture therapeutic goods for the company’s Southport Facility, known as a GMP Licence, by the Australian Therapeutic Goods Administration (TGA). This milestone...

12 hours, 7 minutes ago

2 min read